Home LiteratureArticle Details

PMID: 3950444 Published · ppublish English Clinical Trial Journal Article Randomized Controlled Trial

Clinical evaluation of the immunoadjuvant murabutide, a derivative of MDP, administered with a tetanus toxoid vaccine.

The Journal of infectious diseases ·Vol. 153 ·No. 3 ·1986-03-00 ·Pages 628-33

Telzak E, Wolff SM, Dinarello CA, Conlon T, el Kholy A, Bahr GM, Choay JP, Morin A, Chedid L

Abstract

暂无摘要

MeSH Terms

Acetylmuramyl-Alanyl-Isoglutamine/administration & dosage,analogs & derivatives,immunology Adolescent Adult Antibody Formation Double-Blind Method Enzyme-Linked Immunosorbent Assay Female Hemagglutination Tests Humans Male Middle Aged Tetanus Toxoid/administration & dosage,immunology

Chemicals

Tetanus Toxoid Acetylmuramyl-Alanyl-Isoglutamine murabutide

Authors & Affiliations

9 authors, click to expand affiliations / ORCID

Telzak E

Wolff S M

Dinarello C A

Conlon T

el Kholy A

Bahr G M

Choay J P

Morin A

Chedid L

Article Info

Journal

The Journal of infectious diseases

Abbr.

J Infect Dis

ISSN

0022-1899

DOI

10.1093/infdis/153.3.628

Published

1986-03-00

Pages

628-33

Language

English

Region

United States

NLM ID

0413675

Subset

External Links

PubMed source DOI: 10.1093/infdis/153.3.628 View journal details

Analysis Services

Clinical evaluation of the immunoadjuvant murabutide, a derivative of MDP, administered with a tetanus toxoid vaccine.

Contact

WeChat Official Account